Yoshida, Soichiro http://orcid.org/0000-0003-2757-8083
Takahara, Taro
Arita, Yuki
Ito, Masaya
Hayakawa, Sara
Oguchi, Tomohiko
Komai, Yoshinobu
Numao, Noboru
Yuasa, Takeshi
Inoue, Masaharu
Ushijima, Hiroki
Kudo, Shigehiro
Shimano, Yasumasa
Nakamura, Yuki
Uchida, Yusuke
Uehara, Sho
Tanaka, Hajime
Yaegashi, Hiroshi
Izumi, Kouji
Yokoyama, Minato
Matsuoka, Yoh
Yoshioka, Yasuo
Konishi, Koji
Nakanishi, Katsuyuki
Nagahara, Akira
Hirakawa, Akihiro
Koike, Ryuji
Koga, Fumitaka
Nishimura, Kazuo
Mizokami, Atsushi
Yonese, Junji
Kageyama, Yukio
Yoshimura, Ryoichi
Fujii, Yasuhisa
Funding for this research was provided by:
Bayer
Article History
Received: 23 November 2021
Accepted: 20 February 2023
First Online: 6 March 2023
Declarations
:
: This trial protocol has been reviewed and approved by a Certified Review Board (Tokyo Medical and Dental University: approval No. NR2020-005). The deliberations of this Clinical Research Review Board is to be a review of all participating facilities, and all participating facilities are approved. The protocol has also been reviewed and approved by the director of each participating institution and registered with the Japan Registry of Clinical Trials (jRCT) on March 1, 2021 (registry number jRCTs031200358). The physician in charge will obtain informed consent and written consent forms for potential trial participants before study participation. Informed consent includes consent provisions for the collection and use of participant data in ancillary research.
: Not applicable.
: The authors have no competing interests. This study has received funding from a commercial organization, Bayer Yakuhin, Ltd. (Osaka, Japan).